# Mendel Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mendel-health

- Industry: Healthcare IT
- Headquarters: San Jose, US
- Website: www.mendel.ai
- Total disclosed funding: $58M
- Latest round: Series B (Mar 16, 2022)
- Investors on record: 9

## About

Mendel Health Inc., based in the US, specializes in leveraging artificial intelligence to enhance clinical data workflows, offering innovative solutions for healthcare professionals seeking to streamline their processes and improve decision-making capabilities.Founded in 2016 in San Jose, US, Mendel Health Inc. is a technology company focused on optimizing clinical data workflows through advanced AI tools. The company has completed a total of 9 funding deals, with its most recent being a Series B round in March 2022, where it raised USD 40.00 mn led by Oak HC/FT Partners, alongside DCM and other investors. Karim Galil, one of the co-founders, serves as the CEO, bringing extensive experience in the tech industry to the firm.Mendel AI provides a comprehensive suite of products aimed at enhancing clinical data workflows via advanced artificial intelligence. The central offering, the Hypercube platform, integrates with various business intelligence, ETL, and data ingestion tools, employing over 50 connectors and 20 visualization and SQL tools. This platform empowers healthcare professionals in biopharma, clinical care, and diagnostics to perform tasks like cohort retrieval and chart review, utilizing trusted outputs supported by a clinical hypergraph. Mendel serves a diverse clientele, including significant life sciences companies and educational institutions like the University of Pennsylvania across North America and Europe.Mendel AI generates revenue predominantly through subscription models and partnerships with healthcare organizations. Clients utilize the Hypercube platform alongside customized AI copilots tailored to specific data requirements, typically structured around licensing agreements for software and support services. This approach facilitates tailored applications like cohort analysis and data visualization tools, aligning with each client's unique needs, thereby enabling them to enhance their operational efficiencies and insights from complex clinical datasets.Following its Series B funding round on March 16, 2022, where Mendel Health Inc. raised USD 40.00 mn, the company intends to utilize this investment to scale its commercial organization and expedite product releases. Additionally, plans are in place to expand the team in artificial intelligence and engineering. Mendel aims to introduce new products and expand its presence into new geographic markets, targeting specific regions that align with its growth strategy.

## Funding rounds

- Series B, Mar 16, 2022, $40M — DCM, Oak HC/FT
- Series A, Apr 9, 2021, $13M — DCM, Millennium Technology Value Partners, LaunchCapital, SOSV, BootstrapLabs, IndieBio, Zola Capital Management, LLC, Olive Tree Capital
- Seed, Nov 3, 2019, $3M — DCM
- Seed, Jun 1, 2018 — BootstrapLabs
- Seed, Jul 1, 2017, $2M — DCM, LaunchCapital, BootstrapLabs
- Seed, Apr 3, 2017 — SOSV
- Seed, Aug 31, 2016 — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed, Series A
- DCM (https://capitalatlas.ai/funds/dcm) — Seed, Series A, Series B
- LaunchCapital (https://capitalatlas.ai/funds/launchcapital) — Seed, Series A
- BootstrapLabs (https://capitalatlas.ai/funds/bootstraplabs) — Seed, Series A
- Millennium Technology Value Partners (https://capitalatlas.ai/funds/millennium-technology-value-partners) — Series A
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Series A
- Zola Capital Management, LLC — Series A
- Olive Tree Capital (https://capitalatlas.ai/funds/olive-tree-capital) — Series A
- Oak HC/FT (https://capitalatlas.ai/funds/oak-hc-ft) — Series B